{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:46:13Z","timestamp":1778661973090,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.mito.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T01:56:36Z","timestamp":1305942996000},"page":"679-685","source":"Crossref","is-referenced-by-count":21,"title":["Why are there no proven therapies for genetic mitochondrial diseases?"],"prefix":"10.1016","volume":"11","author":[{"given":"Peter W.","family":"Stacpoole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2011.05.002_bb0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.mito.2011.05.002_bb0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.410190615","article-title":"Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: a 31P-NMR follow-up study","volume":"19","author":"Arogov","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2011.05.002_bb0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondrial, oxidants and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.mito.2011.05.002_bb0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymgme.2004.06.009","article-title":"Chronic treatment of mitochondrial disease patients with dichloroacetate","volume":"83","author":"Barshop","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2011.05.002_bb0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","article-title":"Mitochondria, oxidative damage, and inflammation in Parkinson's disease","volume":"991","author":"Beal","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.mito.2011.05.002_bb0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mito.2006.04.001","article-title":"Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency","volume":"6","author":"Berendzen","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2011.05.002_bb0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/NEN.0b013e3181b40217","article-title":"Peripheral neuropathy in rats exposed to dichloroacetate","volume":"68","author":"Calcutt","year":"2009","journal-title":"J Neuro Sci Exp Neurol"},{"issue":"9342","key":"10.1016\/j.mito.2011.05.002_bb0040","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(02)11310-9","article-title":"Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism?","volume":"360","author":"Chinnery","year":"2002","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.mito.2011.05.002_bb0045","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM197812142992414","article-title":"Dichloroacetate as treatment for congenital lactic acidosis","volume":"299","author":"Coude","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mito.2011.05.002_bb0050","series-title":"Mitochondrial Medicine","author":"DiMauro","year":"2006"},{"issue":"4","key":"10.1016\/j.mito.2011.05.002_bb0055","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1210\/jc.2003-031684","article-title":"Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism","volume":"89","author":"Duncan","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7255","key":"10.1016\/j.mito.2011.05.002_bb0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","article-title":"Recent progress in the biology and physiology of sirtuins","volume":"460","author":"Finkel","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.mito.2011.05.002_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-7192(02)00145-2","article-title":"Coenzyme Q10 and idebenone in the therapy of respiratory chain disorders: rationale and comparative benefits","volume":"77","author":"Geromel","year":"2002","journal-title":"Molecular Genetics and Metabolism"},{"issue":"5","key":"10.1016\/j.mito.2011.05.002_bb0070","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mus.21758","article-title":"A randomized trial of coenzyme Q10 in mitochondrial disorders","volume":"42","author":"Glover","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mito.2011.05.002_bb0075","series-title":"Mitochondrial Medicine: Mitochondrial Metabolism, Diseases, Diagnosis and Therapy","author":"Gvozdjakova","year":"2008"},{"key":"10.1016\/j.mito.2011.05.002_bb0080","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/j.mito.2007.03.008","article-title":"The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease","volume":"7S","author":"Haas","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2011.05.002_bb0085","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/331717a0","article-title":"Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies","volume":"321","author":"Holt","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.mito.2011.05.002_bb0090","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2011.05.002_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.21743","article-title":"Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III","volume":"66","author":"Kaufmann","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2011.05.002_bb0100","first-page":"75","article-title":"Treatment of lactic acidosis: a review","volume":"10","author":"Kerr","year":"1995","journal-title":"Int Pediatr"},{"issue":"11","key":"10.1016\/j.mito.2011.05.002_bb0105","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1212\/WNL.55.11.1748","article-title":"A placebo-controlled crossover trial of creatine in mitochondrial diseases","volume":"55","author":"Klopstock","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mito.2011.05.002_bb0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1468-1331.2004.00970.x","article-title":"Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study","volume":"12","author":"Kornblum","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.mito.2011.05.002_bb0115","series-title":"Q10 in genetic mitochondrial diseases","article-title":"Phase 3 trial of coenzyme","year":"2008"},{"key":"10.1016\/j.mito.2011.05.002_bb0120","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/01.WNL.0000055089.39373.FC","article-title":"Cerebellar ataxia and coenzyme Q10 deficiency","volume":"60","author":"Lamperti","year":"2003","journal-title":"Neurology"},{"issue":"3\u20134","key":"10.1016\/j.mito.2011.05.002_bb0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/ars.2006.8.417","article-title":"New insights into structure and function of mitochondria and their role in aging and disease","volume":"8","author":"Lenaz","year":"2006","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.mito.2011.05.002_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mpd.2003.mpd0333","article-title":"The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: a double-blind randomized crossover clinical trial","volume":"142","author":"Liet","year":"2003","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.mito.2011.05.002_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/138945010790031018","article-title":"Coenzyme Q10 in neuromuscular and neurodegenerative disorders","volume":"11","author":"Mancuso","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.mito.2011.05.002_bb0140","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1212\/WNL.43.5.884","article-title":"Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease","volume":"43","author":"Matthews","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2011.05.002_bb0145","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/WNL.56.7.849","article-title":"Familial cerebellar ataxia with muscle Q10 deficiency","volume":"56","author":"Musumeci","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2011.05.002_bb0155","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1073\/pnas.86.7.2379","article-title":"Muscle coenzyme Q deficiency in familial mitochondrial encephalopathy","volume":"86","author":"Ogasahara","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mito.2011.05.002_bb0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0925-4439(95)00039-7","article-title":"The treatment of mitochondrial myopathies and encephalomyopathies","volume":"1271","author":"Peterson","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2011.05.002_bb0165","series-title":"Images of America: Angel Flight Mid-Atlantic","author":"Rhodes","year":"2008"},{"issue":"2","key":"10.1016\/j.mito.2011.05.002_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mus.20688","article-title":"Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Nuscle Nerve"},{"key":"10.1016\/j.mito.2011.05.002_bb0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mus.20688","article-title":"Beneficial effects of creatine, CoQ10 and lipoic acid in mitochondrial disorders","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mito.2011.05.002_bb0180","first-page":"487","article-title":"Rules of evidence and clinical recommendations for the management of patients","volume":"9","author":"Sackett","year":"1993","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.mito.2011.05.002_bb0185","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.107.134593","article-title":"Age-dependent metabolism of dichloroacetate in rats: possible relevance to human toxicity","volume":"324","author":"Shroads","year":"2008","journal-title":"J Pharmacol Exper Ther"},{"issue":"2","key":"10.1016\/j.mito.2011.05.002_bb0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1289\/ehp.1002554","article-title":"The dichloroacetate dilemma: environmental hazard vs. therapeutic goldmine \u2014 both or neither?","volume":"119","author":"Stacpoole","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mito.2011.05.002_bb0200","doi-asserted-by":"crossref","first-page":"e1223","DOI":"10.1542\/peds.2007-2062","article-title":"Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate","volume":"121","author":"Stacpoole","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.mito.2011.05.002_bb0205","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1542\/peds.2005-1226","article-title":"A controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children","volume":"117","author":"Stacpoole","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.mito.2011.05.002_bb0210","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/03602539808996323","article-title":"Pharmacokinetics, metabolism and toxicology of dichloroacetate","volume":"30","author":"Stacpoole","year":"1998","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.mito.2011.05.002_bb0215","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/adc.77.6.535","article-title":"Treatment of congenital lactic acidosis with dichloroacetate","volume":"77","author":"Stacpoole","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.mito.2011.05.002_bb0220","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0026-0495(89)90051-6","article-title":"The pharmacology of dichloroacetate","volume":"38","author":"Stacpoole","year":"1989","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.mito.2011.05.002_bb0225","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/mds.22023","article-title":"Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial","volume":"23","author":"Stamelou","year":"2008","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/j.mito.2011.05.002_bb0230","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C","article-title":"A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies","volume":"20","author":"Tarnopolsky","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mito.2011.05.002_bb0235","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","article-title":"A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease","volume":"57","author":"The Huntington Study Group","year":"2001","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.mito.2011.05.002_bb0240","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/mds.22408","article-title":"Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects","volume":"25","author":"The Huntington Study Group","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mito.2011.05.002_bb0245","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbamem.2003.11.012","article-title":"Metabolism and function of coenzyme Q","volume":"1660","author":"Turunen","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2011.05.002_bb0250","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","journal-title":"Science"}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724911001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724911001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T01:25:54Z","timestamp":1560216354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724911001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1567724911001905"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2011.05.002","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}